West Pharmaceutical Services WST Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's return on assets?
- West Pharmaceutical Services (WST) reported return on assets of 14% in Q1 2026.
- How has West Pharmaceutical Services's return on assets changed year-over-year?
- West Pharmaceutical Services's return on assets increased by 8.5% year-over-year, from 12.9% to 14%.
- What is the long-term trend for West Pharmaceutical Services's return on assets?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's return on assets has grown at a -10.4% compound annual growth rate (CAGR), from 79.5% to 51.2%.
- What does return on assets mean?
- How much profit the company squeezes out of everything it owns.
- How do you interpret return on assets?
- Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
- How does return on assets compare across companies?
- Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.